Glenmark Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has informed the stock exchange that its trading window is closed in line with SEBI's Prohibition of Insider Trading Regulations, 2015. A trading window closure means that insiders, including directors, employees, and connected persons, are restricted from trading in the company's shares during this period. Such closures are typically done ahead of a board meeting where financial results, quarterly earnings, or other material price-sensitive information are expected to be considered.
This is a routine compliance filing and does not, by itself, have a direct impact on the stock price. However, investors should watch for the upcoming board meeting outcome, which may include results or announcements that could be price-sensitive.